Engineered Bacterium Mutations for Higher Tryptophan Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The production efficiency of L-tryptophan is low due to its long biosynthetic route, requirement for multiple precursors, and strong feedback inhibition, making it difficult for industrial strains to meet market demand, and existing metabolic engineering strategies fail to enhance production effectively.
Innovation Solution
An engineered strain is developed by modifying the pepD and fadR proteins through mutations and enhancing or weakening their expression levels, combined with genome sequencing and mutagenesis techniques, to improve tryptophan production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional metabolic engineering strategies are applied to modify tryptophan biosynthesis pathways, then targeted pathway optimization is achieved, but production efficiency remains insufficient due to the complex metabolic network and feedback inhibition
Solution Approach 1:
The patent applies parameter changes by mutating specific genes (pepD and fadR) to alter protein functions and regulatory parameters. The pepD gene mutation changes the protease activity parameters, while the fadR gene mutation modifies the transcriptional regulation parameters, thereby optimizing tryptophan production without requiring complex pathway redesign
Solution Approach 2:
The patent employs self-service by using the cell's own mutagenesis and selection systems. The error-prone PCR and adaptive evolution processes leverage the organism's intrinsic genetic machinery to generate and select beneficial mutations, reducing the need for external complex engineering interventions
2Productivity
If cytidine deaminase is expressed to induce mutations, then mutation rate increases slightly, but existing strategies cannot achieve rapid enhancement of production
Solution Approach 1:
The patent applies preliminary action by pre-fusing cytidine deaminase with T7 RNA polymerase to create a mutagenesis system that is activated before the actual evolution process. This pre-prepared system enables rapid mutation induction when needed, rather than relying on slow spontaneous mutations or time-consuming sequential engineering steps
Solution Approach 2:
The patent uses T7 RNA polymerase as an intermediary to deliver cytidine deaminase activity to specific genomic regions. The fusion protein acts as a mediator that concentrates mutagenesis activity where it is most needed, accelerating the generation of beneficial mutations without requiring genome-wide mutagenesis
3Adaptability or versatility
If modifications are made to proteins unrelated to main metabolic pathways, then new production capabilities are discovered, but the complexity of metabolic network makes results uncertain and difficult to predict
Solution Approach 1:
The patent applies feedback by implementing adaptive evolution in media containing high concentrations of tryptophan. The selective pressure acts as a feedback signal that guides the accumulation of beneficial mutations. Genome sequencing provides feedback on which mutations are occurring, allowing researchers to identify and propagate successful variants while discarding unsuccessful ones
Solution Approach 2:
The patent replaces traditional rational design approaches with an evolutionary systems approach. Instead of using complex computational models to predict which mutations will work, the system uses directed evolution and selection to empirically identify successful mutations, substituting mathematical prediction with biological experimentation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered strain achieves a 1.48-fold increase in tryptophan production and a 1.26-fold increase in glucose-to-tryptophan yield, reaching 62.38±5.80 g/L in a 5 L fermenter.
Implementation Method 1
the expression of cytidine deaminase only slightly increases the mutation rate
Data Source
Figure 1
AI summary
An engineered strain for improving tryptophan production and a construction method and use thereof are provided. By screening out a strain capable of tolerating high-concentration tryptophan and performing genomic sequencing and protein sequence analysis on the strain, it is found that certain proteins in the strain undergo point mutations and these mutations are capable of enhancing tryptophan production. To increase tryptophan production, protein sequences encoded by fadR or pepD genes in a parent strain are modified. These modifications result in an engineered strain with significantly higher tryptophan production compared to the parent strain. Under scaled-up production conditions, the tryptophan production reaches 62.38 ± 5.80 g/L in a 5 L fermenter, with a glucose-to-tryptophan yield of 24.1%. Compared to an original strain, tryptophan production increases by 1.48-fold, and the glucose-to-tryptophan yield improves by 1.26-fold. The biological materials and its use belong to the technical field of molecular biology and possess broad practical application value.